{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-032511","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2024-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.229227+00:00","generated_at":"2026-05-31T23:16:54.669518+00:00","sec_items":["3.01","5.02"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Director resigns; Nasdaq confirms Gyre out of compliance on audit committee composition","bullets":["Nassim Usman resigned from Board and Audit Committee, effective June 30, 2024, not due to any disagreements.","On July 2, Nasdaq notified Gyre of non-compliance with Listing Rule 5605 (audit committee independence requirements).","Cure period runs until earlier of next annual meeting or June 30, 2025; company is recruiting a new independent director.","Company intends to reestablish compliance within cure period and avoid delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-032511","json":"https://secwatch.observer/filing/0001140361-24-032511.json","markdown":"https://secwatch.observer/filing/0001140361-24-032511.md","text":"https://secwatch.observer/filing/0001140361-24-032511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124032511/0001140361-24-032511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124032511/ef20032140_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:16:54.669518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"587c318b22","claim":"Nassim Usman resigned as Director at GYRE THERAPEUTICS, INC..","evidence_excerpt":"On June 28, 2024, Nassim Usman, Ph.D. informed the Company that he intended to resign from the Board, effective as of June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124032511/0001140361-24-032511-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}